Skip to main content

Agora
Sign in

House bill · H.R. 4299 (119th Congress)

Protecting Patient Access to Cancer and Complex Therapies Act

U.S. House of Representatives

Latest action Feb 2, 2026

Sponsor: Gregory F. Murphy (U.S. Representative, NC-3, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

Would keep Medicare Part B payment for drugs subject to Medicare price negotiation based on average sales price plus 6 percent, and instead require manufacturers to pay a rebate covering the difference between that amount and the negotiated maximum fair price.

AI summary. Not an official summary. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Also referred to House Committee on Ways and Means · U.S. House of Representatives.

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Cosponsors

39

Cosponsors listed on Congress.gov, shown A to Z.

  • Republican28
  • Democratic11

This bill has cosponsors from more than one party.

Shown in neutral colors by design; Agora is non-partisan.

Show the full list (39 names)

Related bills

As identified by Congress.gov.

Full history

  1. Feb 2, 2026

    Introduced

    Introduced in U.S. House

    U.S. House

  2. Jul 7, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  3. Jul 7, 2025

    In committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    U.S. House

  4. Jul 7, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Jul 7, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Show full history (1 earlier event)
  1. Jul 7, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Read the record